Drug Shortage Report for METOCLOPRAMIDE HYDROCHLORIDE INJECTION
Report ID | 131397 |
Drug Identification Number | 02185431 |
Brand name | METOCLOPRAMIDE HYDROCHLORIDE INJECTION |
Common or Proper name | METOCLOPRAMIDEHYDROCHLORIDE INJECTION |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | METOCLOPRAMIDE HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 2ML 10LIVI CA |
ATC code | A03FA |
ATC description | PROPULSIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-01-08 |
Estimated end date | 2021-03-19 |
Actual end date | 2021-02-26 |
Shortage status | Resolved |
Updated date | 2021-03-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-03-02 | French | Compare |
v3 | 2021-03-02 | English | Compare |
v2 | 2021-01-12 | French | Compare |
v1 | 2021-01-12 | English | Compare |
Showing 1 to 4 of 4